| Name | Title | Contact Details |
|---|
Petvisor is a company that delivers a suite of mobile-enabled technologies to pet care professionals, helping them care for pet families. They provide tools to engage customers, streamline operations, and grow businesses in the veterinary health and pe...
SimpleHealth Founded in 2018 and based in New York City, SimpleHealth makes reproductive wellness simple! Operating in 32 states and growing, SimpleHealth is a nationally recognized telehealth provider of reproductive wellness, offering birth control, herpes and cold sore treatment, and over-the-counter supplements` SimpleHealth`s mission is to be the #1 reproductive wellness provider, giving access to those who otherwise wouldn`t be able to find reproductive care in a convenient and affordable way`
CCS Assoc is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Longevity secrets from the worlds longest-lived people.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.